2025, July 22
CLH Dossier Submission Delayed, Final Decision Still Pending
ECHA’s Ethanol Reclassification
The European Chemicals Agency’s (ECHA) review of ethanol classification is at a critical pause. The expected submission of the harmonized classification and labeling (CLH) dossier—a key step for progressing ethanol’s reclassification—was originally scheduled for July 31, 2025. However, this submission has now been delayed indefinitely, postponing the entire process.
What is the CLH dossier and why does it matter?
The CLH dossier contains all scientific evidence and justification for the proposed classification of ethanol, including potential carcinogenic and reproductive toxicity hazards. Once submitted, it triggers ECHA’s Risk Assessment Committee (RAC) review and eventually leads to the European Commission’s harmonized classification decision.
Without this dossier, the formal regulatory process cannot proceed.
Current status and implications
- The dossier submission has been delayed indefinitely, with no confirmed new timeline.
- This means the final classification decision is not expected soon, prolonging the current status quo.
- Companies using ethanol continue to operate under existing classification and labeling requirements.
- Uncertainty remains, especially for sectors such as biocides, cosmetics, fuel, and pharmaceuticals, where a potential reclassification could impact product approval and safety documentation.
What companies should do now
- Stay informed: Regularly monitor ECHA’s updates and the CLH registry for news on dossier submission.
- Maintain current compliance: Continue adhering to existing ethanol classifications in labeling and safety data sheets.
- Prepare for change: Develop contingency plans in case the dossier is submitted and reclassification proceeds.
- Consult experts: Seek advice on risk management, labeling updates, and regulatory strategy to avoid surprises.
At CSB Compliance, we are committed to keeping you updated on this evolving situation and supporting your compliance needs. Contact us for a tailored review or to discuss how this delay might affect your operations.